Document Detail


Cyclophosphamide in exacerbations of multiple sclerosis. Therapeutic trial and a strategy for pilot drug studies.
MedLine Citation:
PMID:  1097604     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
Cyclophosphamide (CY) has been shown to reverse the signs of experimental allergic encephalomyelitis (EAE) even after the onset of neurological deficits. Because of the analogy of EAE to exacerbations of multiple sclerosis (MS) a clinical trial of CY in acute MS exacerbations was undertaken. A 'sequential criterion' method was used to minimize the size of sample needed for this pilot study. CY failed to alter significantly the course of acute exacerbations of MS. Possible reasons for this failure, and the value of the sequential criterion method in pilot studies, are discussed.
Authors:
D A Drachman; P Y Paterson; R T Schmidt; R F Spehlmann
Related Documents :
21772674 - Subarachnoid block for caesarean section in severe preeclampsia.
21973124 - The impact of raised bmi on the outcome of assisted reproduction: current concepts.
1389794 - Renal dialysis in pregnancy.
18256934 - Pregnancy-associated liver disorders.
22639004 - Fetal bradycardia and sinus node dysfunction.
22918664 - Genetic thromobophilia in pregnancy: a case-control study among north indian women.
Publication Detail:
Type:  Clinical Trial; Journal Article; Research Support, U.S. Gov't, P.H.S.    
Journal Detail:
Title:  Journal of neurology, neurosurgery, and psychiatry     Volume:  38     ISSN:  0022-3050     ISO Abbreviation:  J. Neurol. Neurosurg. Psychiatr.     Publication Date:  1975 Jun 
Date Detail:
Created Date:  1975-10-21     Completed Date:  1975-10-21     Revised Date:  2009-11-18    
Medline Journal Info:
Nlm Unique ID:  2985191R     Medline TA:  J Neurol Neurosurg Psychiatry     Country:  ENGLAND    
Other Details:
Languages:  eng     Pagination:  592-7     Citation Subset:  IM    
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Acute Disease
Alopecia / chemically induced
Animals
Clinical Trials as Topic
Cyclophosphamide / adverse effects,  therapeutic use*
Cystitis / chemically induced
Disease Models, Animal
Drug Evaluation
Drug Evaluation, Preclinical
Encephalomyelitis, Autoimmune, Experimental / drug therapy
Female
Humans
Lymphocyte Activation
Male
Multiple Sclerosis / drug therapy*,  immunology
Nausea / chemically induced
Pilot Projects
Rats
Chemical
Reg. No./Substance:
50-18-0/Cyclophosphamide
Comments/Corrections

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  A phenothiazine derivative in the treatment of spasticity.
Next Document:  Cerebral haemorrhages with atypical clinical patterns. A study of cerebral haematomasusing CSF spect...